These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36316463)

  • 1. Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men.
    Teleka S; Orho-Melander M; Liedberg F; Melander O; Jirström K; Stocks T
    Sci Rep; 2022 Oct; 12(1):18336. PubMed ID: 36316463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness.
    Teleka S; Jochems SHJ; Jirström K; Stocks T
    Cancer Med; 2022 Aug; 11(15):2896-2905. PubMed ID: 35285182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.
    Yates DR; Rouprêt M; Drouin SJ; Audouin M; Cancel-Tassin G; Comperat E; Bitker MO; Cussenot O
    World J Urol; 2013 Feb; 31(1):53-9. PubMed ID: 23053209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis.
    Teleka S; Hindy G; Drake I; Poveda A; Melander O; Liedberg F; Orho-Melander M; Stocks T
    PLoS One; 2020; 15(11):e0241711. PubMed ID: 33237904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts.
    Teleka S; Jochems SHJ; Häggström C; Wood AM; Järvholm B; Orho-Melander M; Liedberg F; Stocks T
    Cancer Med; 2021 Feb; 10(4):1431-1438. PubMed ID: 33455057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
    Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
    Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study.
    Shih C; Hotaling JM; Wright JL; White E
    Urol Oncol; 2013 Nov; 31(8):1689-95. PubMed ID: 22795502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan.
    Nagumo Y; Kawai K; Kojima T; Shiga M; Kojo K; Tanaka K; Kandori S; Kimura T; Kawahara T; Okuyama A; Higashi T; Nishiyama H
    Jpn J Clin Oncol; 2020 Sep; 50(9):1068-1075. PubMed ID: 32469066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.
    Teleka S; Häggström C; Nagel G; Bjørge T; Manjer J; Ulmer H; Liedberg F; Ghaderi S; Lang A; Jonsson H; Jahnson S; Orho-Melander M; Tretli S; Stattin P; Stocks T
    Int J Cancer; 2018 Dec; 143(12):3071-3082. PubMed ID: 29756343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
    Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
    Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.
    Knoedler JJ; Boorjian SA; Tollefson MK; Cheville JC; Thapa P; Tarrell RF; Frank I
    BJU Int; 2014 Dec; 114(6):832-6. PubMed ID: 24119219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder.
    Kim HS; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Sci Rep; 2015 May; 5():9626. PubMed ID: 25959144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control Study.
    Martin C; Leiser CL; O'Neil B; Gupta S; Lowrance WT; Kohlmann W; Greenberg S; Pathak P; Smith KR; Hanson HA
    J Natl Cancer Inst; 2018 May; 110(5):527-533. PubMed ID: 29228305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
    Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
    Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
    Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of squamous histology in bladder cancer: a population-based study.
    Izard JP; Siemens DR; Mackillop WJ; Wei X; Leveridge MJ; Berman DM; Peng Y; Booth CM
    Urol Oncol; 2015 Oct; 33(10):425.e7-13. PubMed ID: 26199176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.
    Aron M
    Curr Urol Rep; 2019 Nov; 20(12):80. PubMed ID: 31781939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
    Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
    Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
    Nguyen D; Taheri D; Springer S; Cowan M; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; VandenBussche CJ; Olson MT; Ricardo BF; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
    Virchows Arch; 2016 Oct; 469(4):427-34. PubMed ID: 27520411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.